Actualités

Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.

Djeddi S, Reiss D, Menuet A, Freismuth S, de Carvalho Neves J, Djerroud S, Massana-Muñoz X, Sosson AS, Kretz C, Raffelsberger W, Keime C, Dorchies OM, Thompson J,...

30 avril 2021


Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go.

Dangouloff T, Vrščaj E, Servais L, Osredkar D; SMA NBS World Study Group. Neuromuscul Disord. 2021 Apr 7:S0960-8966(21)00071-7.

17 avril 2021


Muscle Stem Cell Quiescence: Controlling Stemness by Staying Asleep.

Ancel S, Stuelsatz P, Feige JN. Trends Cell Biol. 2021 Mar 2:S0962-8924(21)00031-3.

15 avril 2021


Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy.

Luan P, D'Amico D, Andreux PA, Laurila PP, Wohlwend M, Li H, Imamura de Lima T, Place N, Rinsch C, Zanou N, Auwerx J. Sci Transl Med. 2021 Apr 7;13(588):eabb0319.

07 avril 2021


Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD.

Schmitz A, Pinheiro Marques J, Oertig I, Maharjan N, Saxena S. Front Cell Neurosci. 2021 Feb 18;15:637548

01 avril 2021


The Effect of SMN Gene Dosage on ALS Risk and Disease Severity.

Moisse M, Zwamborn RAJ, van Vugt J, van der Spek R, van Rheenen W, Kenna B, Van Eijk K, Kenna K, Corcia P, Couratier P, Vourc'h P, Hardiman O, McLaughin R, Gotkine M,...

25 mars 2021


An in vitro reconstituted U1 snRNP allows the study of the disordered regions of the particle and the interactions with proteins and ligands.

Campagne S, de Vries T, Malard F, Afanasyev P, Dorn G, Dedic E, Kohlbrecher J, Boehringer D, Cléry A, Allain FH. Nucleic Acids Res. 2021 Mar 2

15 mars 2021


Early detection of evolving critical illness myopathy with muscle velocity recovery cycles.

Tankisi A, Pedersen TH, Bostock H, Z'Graggen WJ, Larsen LH, Meldgaard M, Elkmann T, Tankisi H. Clin Neurophysiol. 2021 Feb 20:S1388-2457(21)00050-X.

05 mars 2021


Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

Kourakis S, Timpani CA, Campelj DG, Hafner P, Gueven N, Fischer D, Rybalka E. Orphanet J Rare Dis. 2021 Mar 4;16(1):117.

04 mars 2021


Genetic neuropathies presenting with CIDP-like features in childhood.

Fernandez-Garcia MA, Stettner GM, Kinali M, Clarke A, Fallon P, Knirsch U, Wraige E, Jungbluth H. Neuromuscul Disord. 2021 Feb;31(2):113-122.

28 février 2021